Who are we?


Signup for

Online registration

Log in to register
your trial

Search a trial




van CCT (UK)

van CCT (UK)

Body composition and colorectal cancer recurrence and survival

- candidate number28465
- NTR NumberNTR6971
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR19-jan-2018
- Secondary IDs2014/1179 WCRF-NL & WCRF International
- Public TitleBody composition and colorectal cancer recurrence and survival
- Scientific TitleBody composition and colorectal cancer recurrence and survival
- hypothesisThere are three main hypotheses:
1.visceral adiposity is associated with increased risk of recurrence and with decreased survival,
2.indicators of low muscle quality (low muscle mass, low muscle attenuation and increased inter-muscular fat areas) are associated with decreased survival,
3.indicators of low muscle quality are associated with decreased survival independent of adipose tissue area, but not with recurrence
- Healt Condition(s) or Problem(s) studiedColorectal cancer, Sarcopenia, Obesity
- Inclusion criteriaStage I-III colorectal cancer
Available CT-scan at diagnosis
- Exclusion criteriaStage IV colorectal cancer; missing or unusable CT scans (i.e. CT scans of poor quality or scans where muscle tissue was partly cut-off).
- mec approval receivedyes
- multicenter trialyes
- randomisedno
- group[default]
- Type[default]
- Studytypeobservational
- planned startdate 1-apr-2015
- planned closingdate31-mrt-2019
- Target number of participants2000
- InterventionsData from two ongoing prospective cohort studies are combined with registry-based data from three hospitals. The prospective cohorts, i.e., the COLON (and EnCoRe studies, started in 2010 and 2012, respectively. For the registry-based data the Netherlands Cancer Registry is used to select all stage I-III CRC patients diagnosed between 2007 and 2013.
- Primary outcomeOverall mortality
- Secondary outcomeRecurrence
- TimepointsOverall mortality and recurrence data will be updated for every paper
- Trial web site
- statusstopped
- CONTACT for SCIENTIFIC QUERIESProf. dr. Ellen Kampman
- Sponsor/Initiator Wageningen University (WUR)
- Funding
(Source(s) of Monetary or Material Support)
Wereld Kanker Onderzoek Fonds (WCRF-NL), World Cancer Research Fund International (WCRF International), Kankeronderzoekfonds Limburg, as part of Health Foundation Limburg, Alpe d’HuZes Foundation, KWF Kankerbestrijding
- Publications
- Brief summaryColorectal cancer patients who are obese or underweight may have a higher chance of recurrence of cancer, or of dying in comparison to patients of normal weight. However, data are sparse and inconsistent. Part of the inconsistency may be explained by differences in body composition: body fatness is often mainly assessed as body mass index (BMI), which does not give information about a persons' fat and or muscle mass. Excess fat mass in combination with low muscle mass – sarcopenic obesity - has been related to worse survival in comparison with persons who do not have a low muscle mass. These findings underline the need to study the associations of muscle and fat mass both separately and combined with recurrence and survival. Within the current proposal, these associations will be studied.

The study will be performed in The Netherlands
- Main changes (audit trail)
- RECORD19-jan-2018 - 1-feb-2018

  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar